Ronaldo among the investors as Whoop raises US$575m

WHOOP has secured US$575m in Series G funding at a US$10.1bn valuation, as the wearable-tech company targets faster international growth and deeper expansion into preventative health services.The round was led by Collaborative Fund and included a mix of institutional, strategic and individual investors spanning sovereign wealth, healthcare and elite sport.Will Ahmed, WHOOP’s founder and chief executive, said: “Our raise brings together the world’s most sophisticated investors, leading health institutions, and iconic global athletes behind the mission to unlock human performance and healthspan. We are building the personal health platform that people use to improve their health and livelihood.”WHOOP said proceeds will support further growth in the US and international expansion across Europe, the Gulf, Latin America and Asia, alongside hiring to build out research, product and go-to-market capacity.The investor syndicate included 2PointZero Group, Qatar Investment Authority, Mubadala Investment Company, Abbott and Mayo Clinic, with additional participation from Macquarie Capital, Glade Brook, B-Flexion, IVP, Foundry, Accomplice, Affinity Partners, Promus Ventures and Bullhound Capital.WHOOP also leaned heavily on sport and culture names as part of the round, listing Cristiano Ronaldo, LeBron James and Rory McIlroy among participating athletes and individual backers.Ronaldo, described by WHOOP as an investor and global ambassador, said: “WHOOP has become one of the most important tools I use to support my long-term health. I am proud to participate in this round because I believe in the future we are building together. No other company has created a health platform this powerful that people are proud to wear.”The company said it now has more than 2.5 million members globally, and reported that bookings grew 103% year-on-year in 2025, exiting the year at a US$1.1bn run rate.WHOOP also said it operated cash-flow positive in 2025 and is hiring for more than 600 roles this year as it invests in expansion and product development.The company positions itself as a screenless wearable paired with a subscription, using continuous biometric data and AI to deliver insights across sleep, recovery, strain and longer-term health markers.Strategic investment from Abbott was highlighted as a healthcare validation play, with WHOOP pitching its platform as moving beyond performance optimisation into mainstream preventative health and early risk detection.